Palvella Therapeutics
Price & Volume
Stats
See moreOpen | $155.97 |
Previous Close | $152.22 |
Day Range | $153.23-$156.40 |
52W Range | $41.71-$161.38 |
Market Cap | $2.2B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.85 |
News
See moreYahoo Finance • 14 days ago
Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026
Yahoo Finance • 27 days ago
Palvella Therapeutics (PVLA) Submits Initial Module of NDA For QTORIN
Yahoo Finance • last month
Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
Yahoo Finance • last month
What to Know About This $476,000 Palvella Therapeutics Insider Sale After a 620% Stock Rally
About
CEO | Mr. Wesley H. Kaupinen |
CFO | Mr. Matthew E. Korenberg |
Address | 353 W. Lancaster Avenue, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |